Previous close | 6.75 |
Open | 6.73 |
Bid | 0.00 x N/A |
Ask | 7.50 x N/A |
Day's range | 6.73 - 6.73 |
52-week range | 5.00 - 17.00 |
Volume | |
Avg. volume | 457,513 |
Market cap | 18.717M |
Beta (5Y monthly) | -0.01 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.06 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Non-regulatory announcement ECDC report shows HAIs are increasing antibiotic use A third of microorganisms causing HAIs (healthcare-associated infections) were found to be resistant to antibiotics, leaving doctors with fewer effective treatment options ...
Findings include 86% of surgical site infections ("SSIs") caused by bacteria from the patients' own nose, skin, or gut and nearly 60% of infections are resistant to antibiotics VANCOUVER, BC / ACCESSWIRE / April 25, 2024 / Ondine Biomedical Inc. (LON:OBI), ...
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the ...